ICON Cost of Goods Sold 2010-2024 | ICLR
ICON annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- ICON cost of goods sold for the quarter ending September 30, 2024 was $1.439B, a 0.73% decline year-over-year.
- ICON cost of goods sold for the twelve months ending September 30, 2024 was $5.849B, a 3.44% increase year-over-year.
- ICON annual cost of goods sold for 2023 was $5.72B, a 3.49% increase from 2022.
- ICON annual cost of goods sold for 2022 was $5.527B, a 39.13% increase from 2021.
- ICON annual cost of goods sold for 2021 was $3.973B, a 100.65% increase from 2020.
| ICON Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $5,720 |
| 2022 | $5,527 |
| 2021 | $3,973 |
| 2020 | $1,980 |
| 2019 | $1,974 |
| 2018 | $1,818 |
| 2017 | $1,027 |
| 2016 | $961 |
| 2015 | $909 |
| 2014 | $903 |
| 2013 | $845 |
| 2012 | $718 |
| 2011 | $612 |
| 2010 | $541 |
| 2009 | $508 |
| ICON Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-09-30 | $1,439 |
| 2024-06-30 | $1,494 |
| 2024-03-31 | $1,471 |
| 2023-12-31 | $1,446 |
| 2023-09-30 | $1,449 |
| 2023-06-30 | $1,430 |
| 2023-03-31 | $1,396 |
| 2022-12-31 | $1,381 |
| 2022-09-30 | $1,376 |
| 2022-06-30 | $1,392 |
| 2022-03-31 | $1,378 |
| 2021-12-31 | $1,357 |
| 2021-09-30 | $1,358 |
| 2021-06-30 | $631 |
| 2021-03-31 | $626 |
| 2020-12-31 | $535 |
| 2020-09-30 | $493 |
| 2020-06-30 | $446 |
| 2020-03-31 | $505 |
| 2019-12-31 | $508 |
| 2019-09-30 | $500 |
| 2019-06-30 | $491 |
| 2019-03-31 | $475 |
| 2018-12-31 | $479 |
| 2018-09-30 | $459 |
| 2018-06-30 | $449 |
| 2018-03-31 | $431 |
| 2017-12-31 | $267 |
| 2017-09-30 | $260 |
| 2017-06-30 | $250 |
| 2017-03-31 | $250 |
| 2016-12-31 | $252 |
| 2016-09-30 | $243 |
| 2016-06-30 | $238 |
| 2016-03-31 | $229 |
| 2015-12-31 | $229 |
| 2015-09-30 | $227 |
| 2015-06-30 | $225 |
| 2015-03-31 | $228 |
| 2014-12-31 | $230 |
| 2014-09-30 | $230 |
| 2014-06-30 | $227 |
| 2014-03-31 | $216 |
| 2013-12-31 | $215 |
| 2013-09-30 | $214 |
| 2013-06-30 | $214 |
| 2013-03-31 | $202 |
| 2012-12-31 | $192 |
| 2012-09-30 | $183 |
| 2012-06-30 | $180 |
| 2012-03-31 | $162 |
| 2011-12-31 | $158 |
| 2011-09-30 | $158 |
| 2011-06-30 | $151 |
| 2011-03-31 | $144 |
| 2010-12-31 | $140 |
| 2010-09-30 | $139 |
| 2010-06-30 | $131 |
| 2010-03-31 | $131 |
| 2009-12-31 | $131 |
| 2009-09-30 | $127 |
| 2009-06-30 | $125 |
| 2009-03-31 | $124 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $17.504B | $8.120B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $98.658B | 12.24 |
| Cencora (COR) | United States | $49.082B | 18.10 |
| DiDi Global (DIDIY) | China | $23.427B | 0.00 |
| Natera (NTRA) | United States | $16.570B | 0.00 |
| Viatris (VTRS) | United States | $15.624B | 4.81 |
| Avantor (AVTR) | United States | $15.178B | 22.75 |
| Revvity (RVTY) | United States | $14.682B | 25.50 |
| BioMerieux (BMXMF) | France | $13.087B | 0.00 |
| CochLear (CHEOY) | Australia | $12.998B | 0.00 |
| Solventum (SOLV) | United States | $12.357B | 0.00 |
| Doximity (DOCS) | United States | $11.372B | 67.31 |
| Medpace Holdings (MEDP) | United States | $11.301B | 31.84 |
| Charles River Laboratories (CRL) | United States | $11.285B | 21.81 |
| HealthEquity (HQY) | United States | $8.756B | 47.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.590B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $7.202B | 33.53 |
| Life Times (LTH) | United States | $5.139B | 34.01 |
| Sotera Health (SHC) | United States | $4.509B | 24.12 |
| Organon (OGN) | United States | $4.144B | 4.18 |
| Surgery Partners (SGRY) | United States | $3.996B | 44.27 |
| BrightSpring Health Services (BTSG) | United States | $3.489B | 74.22 |
| PACS (PACS) | United States | $3.347B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.580B | 0.00 |
| Concentras Parent (CON) | United States | $2.505B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.471B | 0.00 |
| Premier (PINC) | United States | $2.314B | 11.55 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.016B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
| Teladoc Health (TDOC) | United States | $1.689B | 0.00 |
| Progyny (PGNY) | United States | $1.540B | 27.08 |
| Pediatrix Medical (MD) | United States | $1.371B | 13.41 |
| Establishment Labs Holdings (ESTA) | $1.266B | 0.00 | |
| CareDx (CDNA) | United States | $1.252B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.058B | 7.16 |
| Embecta (EMBC) | United States | $0.910B | 6.07 |
| Agilon Health (AGL) | United States | $0.890B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.809B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.723B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
| DocGo (DCGO) | United States | $0.411B | 15.46 |
| Enhabit (EHAB) | United States | $0.403B | 34.83 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| LifeMD (LFMD) | United States | $0.308B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.248B | 0.00 |
| ModivCare (MODV) | United States | $0.231B | 12.54 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Biodesix (BDSX) | United States | $0.205B | 0.00 |
| Nutex Health (NUTX) | United States | $0.152B | 0.00 |
| MultiPlan (MPLN) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| So-Young (SY) | China | $0.088B | 21.28 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.10 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |